Results 81 to 90 of about 9,499,844 (341)

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

Annals of the Rheumatic Diseases, 2020
The provisional EULAR recommendations address several aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus, and the disease caused by SARS-CoV-2, COVID-19 and are meant for patients with rheumatic and musculoskeletal ...
R. Landewé, P. Machado, F. Kroon, H. Bijlsma, G. Burmester, L. Carmona, B. Combe, Massimo Galli, L. Gossec, A. Iagnocco, J. Isaacs, X. Mariette, I. McInnes, U. Mueller-Ladner, P. Openshaw, J. Smolen, T. Stamm, D. Wiek, H. Schulze-Koops   +18 more
semanticscholar   +1 more source

American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2

Arthritis & Rheumatology, 2021
To provide guidance to rheumatology providers on the use of coronavirus disease 2019 (COVID‐19) vaccines for patients with rheumatic and musculoskeletal diseases (RMDs).
J. Curtis, S. Johnson, D. Anthony, R. Arasaratnam, L. Baden, A. Bass, C. Calabrese, E. Gravallese, R. Harpaz, Andrew T. Kroger, R. Sadun, Amy S. Turner, E. Williams, T. Mikuls   +13 more
semanticscholar   +1 more source

Mutation Screening Using Automated Bidirectional Dideoxy Fingerprinting

BioTechniques, 2000
The need continues to grow for mutation identification in genetic disease in both research and clinical settings. We have developed a rapid nonradioactive bidirectional dideoxy fingerprint mutation screening procedure that is performed using an automated
Yuriy O. Shevchenko, Sherri J. Bale, John G. Compton   +2 more
doaj   +1 more source

Proportion of Acceptable Symptom State Nearly Tripled With Improvements in Patient‐Reported Outcomes for All Symptom State Subgroups: A Registry Study of More Than 15,000 Patients With Osteoarthritis in Digital Education and Exercise Therapy

Arthritis Care &Research, EarlyView.
Objective This study investigated trajectories of patient acceptable symptom state (PASS) among participants of digital education and exercise therapy for knee and hip osteoarthritis. Methods A longitudinal observational study among individuals aged at least 40 years who participated in the digital program.
Ali Kiadaliri, L. Stefan Lohmander, Amanda E. Nelson, Leif E. Dahlberg   +3 more
wiley   +1 more source

Role of VEGF Polymorphisms in the Susceptibility and Severity of Interstitial Lung Disease

Biomedicines, 2021
The search for biomarkers that can help to establish an early diagnosis and prognosis of interstitial lung disease (ILD) is of potential interest. VEGF polymorphisms have been implicated in the development of several lung disorders.
Sara Remuzgo-Martínez, Fernanda Genre, Verónica Pulito-Cueto, Belén Atienza-Mateo, Víctor Manuel Mora Cuesta, David Iturbe Fernández, Sonia María Fernández Rozas, Leticia Lera-Gómez, Pilar Alonso Lecue, María Piedad Ussetti, Rosalía Laporta, Cristina Berastegui, Amparo Solé, Virginia Pérez, Alicia De Pablo Gafas, Oreste Gualillo, José Manuel Cifrián, Raquel López-Mejías, Miguel Ángel González-Gay   +18 more
doaj   +1 more source

Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases

Annals of the Rheumatic Diseases, 2021
The safety of the SARSCoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal diseases (RMD) on immunomodulatory therapy is unknown because these individuals were largely excluded from the vaccine trials.
C. Connolly, Jake A. Ruddy, B. Boyarsky, R. Avery, William Werbel, D. Segev, J. Garonzik‐Wang, Julie J. Paik   +7 more
semanticscholar   +1 more source

Treating lupus nephritis patients to lupus low disease activity reduces renal relapse and preserves long‐term kidney function

Arthritis Care &Research, Accepted Article.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE) but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment, and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond YH Yap, KL Lee, Philip H Li, Iris YK Tang, Chak Sing Lau, Shirley CW Chan   +6 more
wiley   +1 more source

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)

RMD Open, 2021
Aim To assess the impact of the COVID-19 pandemic on patients with rheumatic and musculoskeletal diseases (RMDs). Methods REUMAVID is a cross-sectional study using an online survey developed by an international multidisciplinary patient-led collaboration
M. Garrido‐Cumbrera, H. Marzo-Ortega, L. Christen, P. Plazuelo-Ramos, D. Webb, C. Jacklin, S. Irwin, L. Grange, S. Makri, Elsa Frãzao Mateus, S. Mingolla, K. Antonopoulou, S. Sanz-Gómez, J. Correa-Fernández, L. Carmona, V. Navarro-Compán   +15 more
semanticscholar   +1 more source

Development of a personalized visualization and analysis tool to improve clinical care in complex multisystem diseases with application to scleroderma

Arthritis Care &Research, Accepted Article.
Background In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of a scleroderma patient's ...
Ji Soo Kim, John Scott, Lauren Fisher, Lauren N. Smith, Willie Stewart, Adrianne Woods, Rob Smithwright, Diane Koher, Parastoo Aslanbeik, Aalok B. Shah, Brad Tibbils, Samantha I. Pitts, Ayse P. Gurses, Yushi Yang, Ana‐Maria Orbai, Antony Rosen, Laura K. Hummers, Scott L. Zeger, Ami A. Shah   +18 more
wiley   +1 more source

Lived and care experiences of chronic musculoskeletal shoulder pain in Australian adults: A qualitative study

Arthritis Care &Research, Accepted Article.
Objectives Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centred care and informing local service pathways and care guidelines or standards.
Sonia Ranelli, Joanne E. Jordan, Ilana N. Ackerman, Alison Thorpe, Jennifer G. Persaud, Linda J. Woodhouse, Jason Chua, Ben Horgan, Andrew M. Briggs   +8 more
wiley   +1 more source